Viral double-strand RNA-binding proteins can enhance innate immune signaling by toll-like Receptor 3.

Authors: Lai Y,Yi G,Chen A,Bhardwaj K,Tragesser BJ,Rodrigo A Valverde,Zlotnick A,Mukhopadhyay S,Ranjith-Kumar CT,Kao CC,
Address: Department of Molecular & Cellular Biochemistry, Indiana University, Bloomington, Indiana, United States of America.
Journal: PLoS One.


Publication: 2011;6(10):e25837. doi: 10.1371/journal.pone.0025837. Epub 2011 Oct 10.
Free Text: Viral double-strand RNA-binding proteins can enhance innate immune signaling by toll-like Receptor 3.

abstract

toll-like Receptor 3 (TLR3) detects double-stranded (ds) RNAs to activate innate immune responses. While poly(I:C) is an excellent agonist for TLR3 in several cell lines and in human peripheral blood mononuclear cells, Viral dsRNAs tend to be poor agonists, leading to the hypothesis that additional factor(s) are likely required to allow TLR3 to respond to viral dsRNAs. TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. The polymerase from the genotype 2a JFH-1 HCV was a poor enhancer of TLR3 signaling until it was mutated to favor a conformation that could bind better to a partially duplexed RNA. The 1b polymerase also co-localizes with TLR3 in endosomes. RNA-binding capsid proteins (CPs) from two positive-strand RNA viruses and the hepadenavirus hepatitis B virus (HBV) were also potent enhancers of TLR3 signaling by poly(I:C) or viral dsRNAs. A truncated version of the HBV CP that lacked an arginine-rich RNA-binding domain was unable to enhance TLR3 signaling. These results demonstrate that several viral RNA-binding proteins can enhance the dsRNA-dependent innate immune response initiated by TLR3.



Related Articles
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.
PLoS One. 2011
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.
Lai Y, Adhikarakunnathu S, Bhardwaj K, Ranjith-Kumar CT, Wen Y, Jordan JL, Wu LH, Dragnea B, San Mateo L, Kao CC. PLoS One. 2011; 6(10):e26632. Epub 2011 Oct 21.
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
Hepatology. 2012
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
Li K, Li NL, Wei D, Pfeffer SR, Fan M, Pfeffer LM. Hepatology. 2012 Mar; 55(3):666-75. Epub 2012 Jan 30.
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.
Am J Pathol. 2006
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.
Wörnle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Gröne HJ, et al. Am J Pathol. 2006 Feb; 168(2):370-85.
Review Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
Immunol Rev. 2009
Review Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
Seya T, Matsumoto M, Ebihara T, Oshiumi H. Immunol Rev. 2009 Jan; 227(1):44-53.
Review Sensing of viral infection and activation of innate immunity by toll-like receptor 3.
Clin Microbiol Rev. 2008
Review Sensing of viral infection and activation of innate immunity by toll-like receptor 3.
Vercammen E, Staal J, Beyaert R. Clin Microbiol Rev. 2008 Jan; 21(1):13-25.
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.
PLoS One. 2011
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.
Lai Y, Adhikarakunnathu S, Bhardwaj K, Ranjith-Kumar CT, Wen Y, Jordan JL, Wu LH, Dragnea B, San Mateo L, Kao CC. PLoS One. 2011; 6(10):e26632. Epub 2011 Oct 21.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.